Pediatric cannabinoid hyperemesis: Two cases

Pediatric Emergency Care

Volumn 26, Issue 12, 2010, Pages 919-920

  Miller, Joseph B ^a   Walsh, Mark ^b   Patel, Pankaj A ^b   Rogan, Michael ^b   Arnold, Cliff ^b   Maloney, Megan ^b   Donnino, Michael ^c  

^a HENRY FORD HOSPITAL   (United States)

^b is an assistant professor of nursing at Bethel College   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

cannabinoid hyperemesis; cannabinoids; cyclical vomiting; marijuana

Indexed keywords

AMFEBUTAMONE; CANNABINOID; FLUTICASONE; METHYLPHENIDATE; SALBUTAMOL;

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; BIOPSY; CANNABINOID HYPEREMESIS; CANNABIS SMOKING; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; EMERGENCY WARD; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; LABORATORY TEST; MALE; SMOKING CESSATION; TOBACCO; VITAL SIGN; VOMITING;

ADOLESCENT; ANTI-ASTHMATIC AGENTS; ANTIDEPRESSIVE AGENTS; ASTHMA; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BATHS; CANNABIS; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MARIJUANA SMOKING; NAUSEA; RECEPTOR, CANNABINOID, CB1; TOBACCO USE DISORDER; VOMITING;

EID: 78650472742     PISSN: 07495161     EISSN: None     Source Type: Journal    
DOI: 10.1097/PEC.0b013e3181fe9189     Document Type: Article

References (14)

1. Compton WM, Grant BF, Colliver JD, et al. Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. JAMA. 2004;291(17):2114-2121.
2. Allen JH, de Moore GM, Heddle R, et al. Cannabinoid hyperemesis: Cyclical hyperemesis in association with chronic cannabis abuse. Gut. 2004;53(11):1566-1570.
3. Wallace D, Martin AL, Park B. Cannabinoid hyperemesis: Marijuana puts patients in hot water. Australas Psychiatry. 2007;15(2):156-158.
4. Roche E, Foster PN. Cannabinoid hyperemesis: Not just a problem in Adelaide Hills. Gut. 2005;54(5):731.
5. Singh E, Coyle W. Cannabinoid hyperemesis. Am J Gastroenterol. 2008;103(4):1048-1049.
6. Budhraja V, Narang T, Slaiman A. Cannabinoid hyperemesis syndrome: Cyclic vomiting, chronic cannabis use and compulsive bathing. Practical Gastroeneterol. 2008;32(9):79-80.
7. Chang YH, Windish DM. Cannabinoid hyperemesis relieved by compulsive bathing. Mayo Clin Proc. 2009;84:76-78.
8. Sontineni SP, Chaudsrhary S, Sontineni V, et al. Cannabinoid hyperemesis syndrome: Clinical diagnosis of an underrecognized manifestation if chronic cannabis abuse. World J Gastroenterol. 2009;15:1264-1266.
9. Darmani NA, Crim JL. Delta-9-tetrahydrocannabinol differentially suppresses emesis versus enhanced locomotor activity produced by chemically diverse dopamine D2/D3 receptor agonists in the least shrew (Cryptotis parva). Pharmacol Biochem Behav. 2005;80(1): 35-44.
10. Izzo AA, Camilleri M. Emerging role of cannabinoids in gastrointestinal and liver diseases: Basic and clinical aspects. Gut. 2008;57(8):1140-1155.
11. McCallum RW, Soykan I, Sridhar KR, et al. Delta 9 tetrahydrocannabinol delays the gastric emptying of solid food in humans: A double blind, randomized study. Aliment Pharmacol Ther. 1999;13:77-80.
12. Gines P, Schrier RW. Renal failure in cirrhosis. N Engl J Med. 2009;361;1279-1290.
13. Ros J, Claria J, To-Figueras J, et al. Endogenous cannabinoids: A new system involved in the hemostasis of arterial pressure in experimental cirrhosis in the rat. Gastroenterology. 2002;122:86-93.
14. Parfieniuk A, Flisiak R. Role of cannabinoids in chronic liver diseases. World J Gastroenterol. 2008;14(40):6109-6114.